The facility, designed to be the largest land-based salmon farm in Asia, will produce 10,000 tonnes of Atlantic salmon annually.

Four studies published by Purdue University scientists document the feasibility of previously unproven methods for successfully treating wastewater from aquaculture production operations.

The project’s research initiatives include efforts to develop disease-resistant and fast-growing traits through molecular breeding in order to create resilient family lines.

The Eyestalk Ablation-Free Recognition Project is inviting companies to commit to eliminate this practice.

Owners still considering selling its Greek business.

Hatchery-reared juvenile scallops have been successfully deployed for the first time off the coast of Rottnest in a crucial step towards developing a more productive and sustainable saucer scallop fishery for Western Australia.

Ecuador is under an energy crisis due to a prolonged drought due to El Niño that has forced the country to power cuts that are affecting the shrimp industry.

The new fund’s investment mandate includes software, improved fish welfare, and improved ocean health.

The system, developed by Chilean and Colombian researchers, produces copepod eggs for use as first feed in marine fish hatcheries.

Seven of its shrimp farms in Thailand have been granted Antibiotic-Free Product Certification by SGS (Thailand) Company Limited.

A consortium of UK academics and aquaculture partners is exploring the best conditions for delivering vaccines against Aeromonas salmonicida to ballan wrasse.

More than five million pieces of vannamei shrimp seed will be imported to start commercial farming in the country.

The government has approved a project to breed a snapper that is more resistant to disease, grows faster, and can thrive in warmer water.

Ridgeway Biologicals and Mowi Scotland developed a new vaccine strategy to safeguard salmon against the bacteria Yersinia ruckeri.

The Brexit impact has been mitigated by huge growth in other markets, particularly Asia and the US.

Antonio Garza de Yta was appointed as COO of Blue Aqua International-Gulf, a subsidiary of Blue Aqua International, to oversee the shrimp and trout farming projects and a feed mill the company planned in the country.

A public-private initiative aims to implement new solutions to prevent bacterial diseases and reduce the use of antibiotics.

The technology could be scaled up to make mass antigens available to later be applied via salmon feeds as an oral vaccine.

A strain was designed to thrive in brackish water and estuarine environments to prevent mass mortalities due to saltwater intrusions.

The company has taken the delivery of the first batch of “green” eggs at its new £2 million incubation unit at Barcaldine Hatchery.